COVID-19 tied to elevated risk of benign prostatic hyperplas

SARS-CoV-2 infection linked to increased benign prostatic hyperplasia (BPH) complications and medication use. Urological manifestations in COVID-19 patients emphasize the importance of awareness among clinicians.

Related Keywords

Hong Kong , , Hong Kong Hospital Authority , Internal Medicine , Hong Kong Hospital , Coronavirus Disease Covid 19 , Prostate , Ce2 , Ngiotensin , Ngiotensin Converting Enzyme 2 , Benign Prostatic Hyperplasia , Coronavirus , Diabetes , Diabetes Mellitus , Nzyme , Hematuria , Hyperplasia , Medicine , Metabolic Syndrome , Espiratory , Cars , Ars Cov 2 , Serine , Evere Acute Respiratory , Evere Acute Respiratory Syndrome , Yndrome ,